PHENOSTICS
DEAD

Serial Number

78337120

Owner

AMERSHAM PLC

Attorney

Catherine Mennenga

Filing Date

Dec 5, 2003

Add to watchlist:

No watchlists yet
View on USPTO

PHENOSTICS Trademark

Serial Number: 78337120

PHENOSTICS is a trademark filed by AMERSHAM PLC on December 5, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

Trademark Details

Filing Date

December 5, 2003

Registration Date

Not Registered

Published for Opposition

November 15, 2005

Goods & Services

Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research and for nuclear cardiology and medical imaging, for use by laboratories, pharmacies, doctors, hospitals, and medical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods

Diagnostic agents, preparations and substances for medical diagnostic purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; radioisotope brachytherapy substances; and gases and gas mixtures for medical imaging

Chemicals and chemical reagents for use in industry, science and research; biochemical and biological preparations for use in industry, science and research; chemical preparations for scientific purposes; preparations for diagnosis for scientific purposes; radioactive elements, isotopes, preparations and reagents for industrial, research and scientific purposes; gases and gas mixtures for industrial, research and scientific purposes

Medical diagnostic services; medical imaging services; providing medical information to pharmaceutical companies and medical professionals

Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, comprised of medical needles, suture needles, implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goods

Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences, high through put screening assays for drug development services; research and product development for others, namely, research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicine, pharmaceuticals and biochemistry; radiolabeling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 11, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 11, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2006 NOAM
PUBLISHED FOR OPPOSITION
Nov 15, 2005 PUBO
NOTICE OF PUBLICATION
Oct 26, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 20, 2005 PREV
ASSIGNED TO LIE
Sep 16, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Sep 12, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 12, 2005 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 12, 2005 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 6, 2005 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 11, 2005 PREV
ASSIGNED TO LIE
Aug 5, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Aug 2, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 2, 2005 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 14, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 14, 2005 REAP
FINAL REFUSAL E-MAILED
Jan 4, 2005 GNFR
FINAL REFUSAL WRITTEN
Jan 4, 2005 CNFR
AMENDMENT FROM APPLICANT ENTERED
Dec 10, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2004 CRFA
PAPER RECEIVED
Nov 22, 2004 MAIL
NON-FINAL ACTION E-MAILED
Jul 15, 2004 GNRT
ASSIGNED TO EXAMINER
Jun 29, 2004 DOCK
NEW APPLICATION ENTERED
Dec 31, 2003 NWAP